查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417941

语音生物标记市场报告：2030 年趋势、预测与竞争分析

Speech Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

语音生物标记趋势和预测

预计到 2030 年，全球言语生物标记市场将达到约 14.9 亿美元，2024 年至 2030 年CAGR为16.7%。该市场的主要驱动力是言语障碍患病率的增加以及人们对言语生物标记的认识不断提高。全球言语生物标记市场的未来看起来充满希望，精神障碍和呼吸衰竭市场存在机会。

按段分類的语音生物标记

该研究包括按类型、应用和区域对全球语音生物标记进行的预测。

语音生物标记市场洞察

Lucintel 预测，由于频率在评估各种言语障碍方面的利用率不断提高，因此在预测期内仍将是最大的部分。

在这个市场中，精神障碍仍将是较大的市场区隔。

由于主要製药公司在该地区的存在，北美在预测期内仍将是最大的地区。

常问问题

Q1. 市场规模は:

A1。到 2030 年，全球语音生物标记市场预计将达到 14.9 亿美元。

Q2. 市场の成长予测は:

A2。预计 2024 年至 2030 年，全球语音生物标记市场将以 16.7% 的CAGR成长。

Q3. 市场の成长に影响を与える主な促进要因は:

A3。该市场的主要驱动力是言语障碍盛行率的增加以及人们对言语生物标记的认识不断提高。

Q4. 市场の主要セグメントは:

A4。言语生物标记市场的未来看起来充满希望，精神障碍和呼吸衰竭市场也充满机会。

Q5. 市场の主要企业は:

A5。一些主要的语音生物标记公司如下。

  • Boston Technology
  • Cogito
  • IBM
  • Conversation HEALTH
  • Winterlight Labs

Q6. 今后、最大となる市场セグメントは:

A6。 Lucintel 预测，由于频率在评估各种言语障碍方面的利用率不断提高，因此在预测期内仍将是最大的部分。

Q7. 市场において、今后5年间に最大になると予想される地域は:

A7。由于主要製药公司在该地区的存在，北美在预测期内仍将是最大的地区。

Q8. レポートのカスタマイズは可能か:

A8。是的，Lucintel 提供 10% 的客製化服务，无需任何额外费用。

目录

第 1 章：执行摘要

第 2 章：全球语音生物标记市场：市场动态

  • 简介、背景和分类
  • 供应链
  • 产业驱动因素与挑战

第 3 章：2018 年至 2030 年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球语音生物标记市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球语音生物标记市场
    • 频率
    • 振幅
    • 错误率
    • 发音时间
  • 全球语音生物标记市场（按应用）
    • 精神障碍
    • 呼吸衰竭
    • 其他

第 4 章：2018 年至 2030 年按地区分類的市场趋势与预测分析

  • 按地区分類的全球语音生物标记市场
  • 北美语音生物标记市场
    • 北美语音生物标记市场（按应用）：精神障碍、呼吸衰竭等
  • 欧洲语音生物标记市场
    • 欧洲语音生物标记市场（按类型）：频率、幅度、错误率和发音时间
    • 欧洲语音生物标记市场（按应用）：精神障碍、呼吸衰竭等
  • 亚太地区语音生物标记市场
    • 亚太地区语音生物标记市场（按类型）：频率、幅度、错误率和发音时间
    • 亚太地区语音生物标记市场（按应用）：精神障碍、呼吸衰竭等
  • ROW 语音生物标记市场
    • ROW 语音生物标记市场（按类型）：频率、幅度、错误率和发音时间
    • ROW 语音生物标记市场（依应用）：精神障碍、呼吸衰竭等

第 5 章：竞争对手分析

  • 产品组合分析
  • 营运整合
  • 波特五力分析

第 6 章：成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球语音生物标记市场的成长机会
    • 全球语音生物标记市场的成长机会（按应用）
    • 按地区分類的全球语音生物标记市场的成长机会
  • 全球语音生物标记市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球语音生物标记市场的容量扩张
    • 全球语音生物标记市场的合併、收购和合资企业
    • 认证和许可

第 7 章：领先企业的公司简介

  • Boston Technology
  • Cogito
  • IBM
  • Conversation HEALTH
  • Winterlight Labs
简介目录

Speech Biomarker Trends and Forecast

The future of the global speech biomarker market looks promising with opportunities in the mental disorder and respiratory failure markets. The global speech biomarker market is expected to reach an estimated $1.49 billion by 2030 with a CAGR of 16.7% from 2024 to 2030. The major drivers for this market are increasing prevalence of speech disorders and rising awareness towards speech biomarkers among people.

A more than 150-page report is developed to help in your business decisions.

Speech Biomarker by Segment

The study includes a forecast for the global speech biomarker by type, application, and region.

Speech Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Frequency
  • Amplitude
  • Error Rate
  • Pronunciation Time

Speech Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Mental Disorder
  • Respiratory Failure
  • Other

Speech Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Speech Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies speech biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the speech biomarker companies profiled in this report include-

  • Boston Technology
  • Cogito
  • IBM
  • Conversation HEALTH
  • Winterlight Labs

Speech Biomarker Market Insights

Lucintel forecasts that frequency will remain the largest segment over the forecast period due to its increasing utilization for evaluating various speech disorders.

Within this market, mental disorder will remain the larger segment.

North America will remain the largest region over the forecast period due to presence of major pharmaceutical companies in the region.

Features of the Global Speech Biomarker Market

Market Size Estimates: Speech biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Speech biomarker market size by type, application, and region in terms of value ($B).

Regional Analysis: Speech biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the speech biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the speech biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the speech biomarker market size?

Answer: The global speech biomarker market is expected to reach an estimated $1.49 billion by 2030.

Q2. What is the growth forecast for speech biomarker market?

Answer: The global speech biomarker market is expected to grow with a CAGR of 16.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the speech biomarker market?

Answer: The major drivers for this market are increasing prevalence of speech disorders and rising awareness towards speech biomarkers among people.

Q4. What are the major segments for speech biomarker market?

Answer: The future of the speech biomarker market looks promising with opportunities in the mental disorder and respiratory failure markets.

Q5. Who are the key speech biomarker market companies?

Answer: Some of the key speech biomarker companies are as follows.

  • Boston Technology
  • Cogito
  • IBM
  • Conversation HEALTH
  • Winterlight Labs

Q6. Which speech biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that frequency will remain the largest segment over the forecast period due to its increasing utilization for evaluating various speech disorders.

Q7. In speech biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to presence of major pharmaceutical companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the speech biomarker market by type (frequency, amplitude, error rate, and pronunciation time), application (mental disorder, respiratory failure, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Speech Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Speech Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Speech Biomarker Market by Type
    • 3.3.1: Frequency
    • 3.3.2: Amplitude
    • 3.3.3: Error Rate
    • 3.3.4: Pronunciation Time
  • 3.4: Global Speech Biomarker Market by Application
    • 3.4.1: Mental Disorder
    • 3.4.2: Respiratory Failure
    • 3.4.3: Other

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Speech Biomarker Market by Region
  • 4.2: North American Speech Biomarker Market
    • 4.2.2: North American Speech Biomarker Market by Application: Mental Disorder, Respiratory Failure, and Other
  • 4.3: European Speech Biomarker Market
    • 4.3.1: European Speech Biomarker Market by Type: Frequency, Amplitude, Error Rate, and Pronunciation Time
    • 4.3.2: European Speech Biomarker Market by Application: Mental Disorder, Respiratory Failure, and Other
  • 4.4: APAC Speech Biomarker Market
    • 4.4.1: APAC Speech Biomarker Market by Type: Frequency, Amplitude, Error Rate, and Pronunciation Time
    • 4.4.2: APAC Speech Biomarker Market by Application: Mental Disorder, Respiratory Failure, and Other
  • 4.5: ROW Speech Biomarker Market
    • 4.5.1: ROW Speech Biomarker Market by Type: Frequency, Amplitude, Error Rate, and Pronunciation Time
    • 4.5.2: ROW Speech Biomarker Market by Application: Mental Disorder, Respiratory Failure, and Other

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Speech Biomarker Market by Type
    • 6.1.2: Growth Opportunities for the Global Speech Biomarker Market by Application
    • 6.1.3: Growth Opportunities for the Global Speech Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Speech Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Speech Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Speech Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Boston Technology
  • 7.2: Cogito
  • 7.3: IBM
  • 7.4: Conversation HEALTH
  • 7.5: Winterlight Labs